Oncology 102: (On-Demand) Winter 2024 - Nebraska Medicine

Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (On-Demand) Winter 2024

The demand for cancer care is expected to increase by 40% over the next six years; however, ASCO is projecting a shortage of more than 2,200 oncologists by 2025. To meet the cancer care needs of all patients, advanced practice providers (APPs), whose education and training focus on health promotion, disease prevention, and primary care medical management, have been increasingly sought-after to fill this shortage. However, many new APPs have little background and training in oncology. As a result, oncology practices need to provide new staff with an onboarding program to help further their knowledge of hematology and oncology.

To assist APPs in their new careers in oncology-based practices, Horizon CME, in partnership with APAO, has developed “Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers.” In this two-and-a-half-day virtual program, clinicians will gain a greater understanding of cancer treatment, cancer therapies, side effects, supportive care strategies, palliative care, and more. Expert faculty will provide a detailed review of treatment strategies for hematologic disorders and solid malignancies. Participation in the program will allow APPs to build upon the foundational knowledge acquired in Oncology 101 and provide APPs with a deeper understanding of the cancer treatment strategies they need to support and care for cancer patients as part of the multidisciplinary oncology care team.

 

Learning Objectives.

  1. Outline strategies for the treatment of common solid and hematologic malignancies
  2. Summarize the role of genetics and molecular testing in cancer care 
  3. Implement palliative care and pain management strategies for patients with cancer
  4. Discuss strategies for the administration and management of chemotherapy
  5. Identify and appropriately manage immune-related adverse events
  6. Recognize and treat the adverse effects associated with radiation oncology

Target Audience

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.

Presented By

                                                                  

Course summary
Available credit: 
  • 14.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 14.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 14.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 14.00 credit.
  • 2.25 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 2.25 credit.
Course opens: 
07/08/2024
Course expires: 
07/08/2025
Cost:
$125.00
Rating: 
0

Commercial Support: Oncology 102: An In-Depth Hematology and Oncology Review for Advanced Practice Providers (On-Demand) Winter 2024 is supported in part by independent medical educational grants from Novocure, Inc., Merck Sharp & Dohme Corp., and Bristol Myers Squibb Company.

 

(01) Biomarker Testing 22:19 minutes (0.50 Credit)
» Rasheda Persinger, MS, AGNP-C, AOCNP - Johns Hopkins Sibley Memorial Hospital

(02) Patience and Understanding: Palliative Care for the APP 49:44 minutes (0.75 Credit)
» Alicia M. Rigby, MSN, RN, APRN, AOCNP - University of California, Davis

(03) Pain Management: An Integral Component of Caring for the Oncology Patient 61:44 minutes (1 Credit)
» Tanya Uritsky, PharmD, BCPP - University of Pennsylvania 

(04) What is Chemotherapy 56:45 minutes (1 Credit)
» Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP - University of Illinois College of Pharmacy

(05) Treating Melanoma in 2023: The Age of Immunotherapy and Targeted Therapy 32:27 minutes (0.50 Credit)
» Grace Cherry, NP - UCLA Health                                                          

(06) Identification and Management of Immune Related Adverse Events 37:24 minutes (0.50 Credit)
» Suzanne McGettigan, CRNP - Abramson Cancer Center

(07) Deciphering Radiation Oncology: A Deeper Dive into Acute and Late Effects from Treatment  29:33 minutes (0.50 Credit)
» Bridgett Harr, CNP - Cleveland Clinic       

(08) Neuro-Oncology for the APP: What is Going on Up There? 32:52 minutes (0.50 Credit)
» Vanessa Nevins, PA-C, RDMS, RT - Yale New Haven Smilow Cancer Hospital

(09)  Breast Oncology: Awareness and Current Knowledge 56:34 minutes (1 Credit)
» Kayla Freeman, DNP, APRN, FNP-C - Emory Winship Cancer Institute

(10) Gynecologic Malignancies: Clinical Pearls 28:49 minutes (0.50 Credit)
» Rachel Frankenthal, PA-C - UCLA Health

(11) Lung Cancer: Updates and Advancements 53:11 minutes (1 Credit)
» Beth Sandy, MSN, CRNP - University of Pennsylvania

(12) Updates in Treating and Managing Patients with Prostate, Bladder and Renal Cell Carcinoma  63:08 minutes (1 Credit)
» Brenda Martone, MSN, ANP-BC, AOCNP - Northwestern Medicine                     
» Laura S. Wood, RN, MSN, OCN - Cleveland Clinic             

(13) Head and Neck Cancer: Diagnosis, Staging, and Management 55:46 minutes (1 Credit)
» Faith Mutale, DNP, CRNP - University of Pennsylvania 

(14) Colorectal and Gastric Cancer: Current and Emerging Therapies 47:15 minutes (0.75 Credit)
» Nina Grenon, NP - Dana-Farber Cancer Institute

(15) A Deep Dive into Multiple Myeloma 69:22 minutes (1 Credit)
» Sara DiCamillo, PA-C, MPH - Winship Cancer Institute, Emory University   
» Donna Catamero, ANP-BC, AOCN, CCRC - Icahn School of Medicine at Mount Sinai Hospital  

(16) Advances in CLL and Follicular Lymphoma for the Clinical Oncology APP 59:07 minutes (1 Credit)
» Amy Goodrich, RN, MSN, CRNP - Johns Hopkins  

(17) Understanding and Managing Acute Leukemia, Myelodysplastic Syndrome, and Myelofibrosis 45:46 minutes (0.75 Credit)
» Jennie M. Goble, PA-C - Mayo Clinic

(18) An Update of Current Treatment Options for Patients with Diffuse Large B-Cell Lymphoma 45:15 minutes (0.75 Credit)
» Christopher D'Andrea, PA-C - Cleveland Clinic

Planning Committee

 

Beth Faiman, PHD, MSN, APN-BC, AOCN, BMTCN, FAAN

Nurse Practitioner

Department of Hematology and Medical Oncology Cleveland Clinic

Cleveland, OH

 

Beth Sandy, MSN, CRNP

Nurse Practitioner, Thoracic Medical Oncology

Abramson Cancer Center, University of Pennsylvania

Philadelphia, PA

 

Ryan Beechinor, PharmD, BCPS, BCOP

Clinical pharmacist

UC Davis Comprehensive Cancer Center

San Francisco, CA

 

Leigh Ann Childress MSN, NP, AOCNP

Director of Advanced Practice 

Clearview Cancer Institute

Huntsville, AL

 

Danielle Roberts PA-C

Physician assistant with the Bone Marrow Transplant team 

Winship Cancer Institute of Emory University

Atlanta, GA

 

Faculty

 

Rasheda Persinger MS, AGNP-C, AOCNP 

Lead Medical Oncology Nurse Practitioner

Johns Hopkins Sibley Memorial Hospital

Washington, DC

 

Alicia M. Rigby MSN, RN, APRN, AOCNP

Nurse Practitioner

UC Davis Cancer Center

Sacramento, CA

 

Tanya Uritsky PharmD, BCPP 

Opioid Stewardship Coordinator 

University of Pennsylvania (HUP)

Philadelphia, PA

 

Jennie M. Goble, PA-C

Instructor in Medicine

 Mayo Clinic

 Rochester, MN

 

Grace Cherry, NP

Nurse Practitioner

UCLA Health

Los Angeles, CA

 

Suzanne McGettigan CRNP

Oncology Nurse Practitioner and Clinical Manager of Advanced Practice Providers and Nursing

Perelman Center for Advanced Medicine, Abramson Cancer Center

Philadelphia, PA

 

Bridget Harr CNP

Nurse Practitioner

Cleveland Clinic

Cleveland, OH

 

Ellen Marin, PA-C

Physician Assistant

Winship Cancer Institute of Emory University

Atlanta, GA

 

Linda M. Perry, MS, PA-C

Physician Assistant

Perelman Center for Advanced Medicine

Philadelphia, PA

 

Meredith Beaton, MSN, RN, AG-ACNP

Nurse Practitioner

UCHealth Anschutz

Aurora, CO

 

Korie Bigbee DNP

Nurse Practitioner Specialist

Kaiser Permanente at City of Hope

 Duarte CA

 

Kathleen Boyle, DScPAS, PA-C 

Physician Assistant

Dana-Farber Cancer Institute

Boston, MA

 

Heather Koniarczyk, MSN, APRN-CNP, AOCNP

Adult Nurse Practitioner

Cleveland Clinic -Taussig Cancer Institute

Cleveland, OH

 

Jessica Walchonski, PA-C

Physician Assistant

UCLA Health

Los Angeles, CA

 

Grace Baek, PharmD, BCOP

Clinical Pharmacist, Hematology/Oncology

Fred Hutchinson Cancer Center

Seattle, WA

 

Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP

Clinical Oncology Pharmacist

University of Illinois College of Pharmacy

Chicago, IL

 

Jennifer Murphy, PharmD, BCOP

Senior Pharmacist

UCD Health, Oncology, and Investigational Drug Service

San Francisco, CA

 

Laura Wood, RN, MSN, OCN 

Nurse

Cleveland Clinic, Taussig Cancer Center

Cleveland, OH

 

Michael Lai, ARNP

Nurse Practitioner

Fred Hutchinson Cancer Center

Seattle, WA

 

Lisa Nodzon PhD, APRN, AOCNP

Nurse Practitioner

H. Lee Moffitt Cancer Center and Research Institute

Tampa, FL

 

Patricia Mangan, RN, MSN, CRNP

Nurse Lead, Hematologic Malignancies Program

Abramson Cancer Center,

University of Pennsylvania

Philadelphia, PA

 

DISCLOSURES:

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.

All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.

Planners

Those others involved in the planning of this activity disclosed no relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Other Contributors

All other non-faculty contributors and others involved in the planning, development and editing/review of the content disclosed no relevant financial relationships with any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients.

Faculty, Authors, and Content Developers Disclosures:

•    Rasheda Persinger, MS, AGNP-C, AOCNP discloses Advisory Board with AstraZeneca but that relationship has ended and Speaker's bureau with Guardant and Astra Zeneca and Advisory Boards, Consulting Fee's with AstraZeneca during the past 24 months.
•    Sandra Cuehllar, PharmD, BCOP, FHOPA, FASHP discloses speaker's bureau with Mirati and Advisory Board with Genetech during the past 24 months.
•    Suzanne McGettigan, CRNP discloses Speaker's Bureau with Regeneron, BMS, Pfizer, and Consulting Fee's with Merck during the past 24 months.
•    Rachel Frankenthal, PA-C discloses Advisory Boards with ImmunoGenX, and GSK but that relationship has ended during the past 24 months.
•    Laura S. Wood, RN, MSN, OCN discloses speaker's bureau with AVEO, BMS, EMD Serono, Exelixis, Merck, Pfizer during the past 24 months.
•    Faith Mutale, DNP, CRNP discloses Speaker's Bureau, Services for Promotional purposes with Merck, Helsinn, Consulting Fee's with Merck, Pfizer, Helsinn, and Advisory Board with Pfizer during the past 24 months.
•    Donna Catamero, ANP-BC, OCN, CCRC disclosed Speaker Bureau with BMS and GSK but that relationship has ended, Advisory Boards with Janssen Phar maceutical, Legend Biotech and Consulting Fee's with BMS during the past 24 months.
•    Amy Goodrich, RN, MSN, CRNP discloses Advisory Board with BeiGene, Abbvie, AstraZeneca, Epizyme, Janssen, Sano during the past 24 months.

.

Planners:

•    Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN discloses consulting fee's with Janssen, Sanofi, GSK, Pfizer during the past 24 months. 
•    Beth Sandy, MSN, CRNP discloses speaker's bureau with Merck, Amgen, Astra Zeneca, Lilly, Advisory Board with Takeda, Jazz, Janseen and Consulting Fee with Abbvie during the past 24 months.
•    Leigh Ann Childress, MSN, NP, AOCNP discloses Advisory Board with Janssen but that relationship has ended and Speaker's Bureau with AstraZeneca , Seagen , Amgen , Merck during the past 24 months.
•    Ryan Beechinor, PharmD, BCPS, BCOP discloses current consulting fee's with IQVIA, Cempra, ORM, Aptitude, Dedham and had contracted research with NIH and COG but that relationship has ended during the past 24 months.
•    Beth Sandy, MSN, CRNP discloses speaker's bureau with Merck, Amgen, Astra Zeneca, Lilly, Advisory Board with Takeda, Jazz, Janseen and Consulting Fee with Abbvie during the past 24 months.
•    Rachel Frankenthal, PA-C discloses Advisory Boards with ImmunoGenX, and GSK but that relationship has ended during the past 24 months.

Available Credit

  • 14.00 AMA PRA Category 1 Credit™
    Horizon CME designates this Enduring activity for a maximum of 14.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 14.00 ANCC
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 14.00 credit.
  • 2.25 Pharmacology
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. Upon completion, NPs and RNs will be awarded up to 2.25 credit.

Price

Cost:
$125.00
Please login or register to take this course.

Required Hardware/software

Access to the internet is required.

Supported Browsers:

Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above

Google Chrome 28.0+ for Windows, Mac OS, or Linux

Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux

Safari 6.0+ for Mac OSX 10.7 and above

 

Supported Phones & Tablets:

 Android 4.0.3 and above

iPhone/iPad with iOS 6.1 or above